Oligo dT(25) Affinity Chromatography Resin
Biovanix Oligo dT(25) Affinity Resin is a cutting-edge solution designed for the purification and isolation of mRNA from in vitro transcription (IVT) manufacturing processes. This advanced resin selectively captures mRNA via its polyadenylated (polyA) tail, effectively separating it from other components of the transcription reaction, such as enzymes and plasmid DNA.
Perfectly suited for large-scale downstream purification, Biovanix Oligo dT(25) Affinity Resin is a key enabler for vaccine and gene therapy applications, offering unmatched selectivity and capacity to meet the demands of modern biopharmaceutical manufacturing.
50 μm
Particle Size
200 nm
Pore Size
pH 2–13
Stability Range
Max Pressure
Stability Range
Product Features
Engineered for High-Performance mRNA Purification
Biovanix Oligo dT(25) Affinity Resin combines selective polyA capture with a rigid PS-DVB matrix for reliable results at any scale.
1. Selective mRNA Capture
✔ PolyA Tail Specificity: Targets mRNA with high selectivity, ensuring effective removal of plasmid DNA and other IVT components.
✔Simple Salt and Water Elution: Streamlined purification process with minimal complexity.
2. Scalable Solution
✔ Excellent Scalability: Designed for seamless transition from lab-scale to large-scale production.
✔ High Capacity: Meets the demands of high-yield mRNA manufacturing.
3. Non-Animal Derived
✔ Synthetic Manufacturing Process: Biovanix oligo ligands are free of animal components, ensuring compliance with regulatory requirements and ethical standards.
4. Simplified Workflow
✔ Reduced Complexity: Eliminates the need for multiple purification steps, maximizing efficiency and reducing downstream processing complexity.
✔ Consistent Performance: Reliable results across different scales and production batches.
How It Works
Simple 4-Step mRNA Purification Workflow
From crude IVT mixture to purified mRNA in a single affinity capture step — no complex multi-step protocols required.
①
Equilibrate
Prepare column with high-salt binding buffer (e.g., 0.5 M NaCl)
②
Load & Bind
Apply IVT mixture; polyA-tailed mRNA binds to poly(dT) ligands
③
Wash
Remove impurities (enzymes, pDNA, nucleotides) in flow-through
④
Elute
Release purified mRNA with water or low-salt buffer
Technical Specifications
Product Specifications
Comprehensive technical data for method development and process validation.
| Characteristic | Description |
| Support Matrix | Cross-linked poly(styrene-divinylbenzene) |
| Average Particle Size | 50 um |
| Average Pore Size | 200 nm |
| Surface Functionality | poly(dT) 25mer with proprietary linker |
| Ligand Density | 0.3 umol/ml |
| Mechanical Resistance | 70 bar (1,000 psi; 7 MPa) |
| Thermal Stability | allows sample denaturing at 65°C if needed |
| pH Range | 2-13 |
| Ionic Strength Range | 0 to 5 M, all common salts |
| Chemical Resistance | Common agents for mRNA purification, include 0.5 M NaOH, 2 M MgCl2, 20 mM EDTA. Water, 0 to 100% alcohol, acetonitrile, 2 M acetic acid, 1 M HCl, and other common organic solvents |
| Storage | 18-20% ethanol |
Chemical & Thermal Resistance
| pH Range | 2–13 |
| Ionic Strength Range | 0 to 5 M, all common salts |
| Buffer Additives | Common agents for mRNA purification, include 0.5 M NaOH, 2 MMgCl2, 20 mM EDTA. Do not expose to strong oxidizers (such as hypochlorite), oxidizing acids (such as nitric), strong reducing agents (such as sulfite), acetone, THF, or benzyl alcohol. |
| Solvents | Water, 0 to 100% alcohol, acetonitrile, 2 M acetic acid, 1 M HCl, and other common organic solvents. Do not expose to strong oxidizers (such as hypochlorite), oxidizing acids (such as nitric), strong reducing agents (such as sulfite), acetone, benzyl alcohol, or THF. |
| Flow rate | Adjust flow rate depending on performance. Do not exceed upper-pressure limitations. |
Benefits at a Glance
Why Biovanix Oligo dT(25) Resin
Designed to maximize purity, simplify workflows, and reduce total cost of ownership.
⚡
High Efficiency
Rapid and efficient mRNA purification.
📈
Scalable Process
Easily adaptable to large-scale manufacturing.
🛡️
Regulatory Compliance
Non-animal derived and synthetic manufacturing process.
💰
Cost-Effective
Simplified workflow reduces operational complexity and costs.
Applications
Built for the mRNA Revolution
From vaccine development to gene therapy manufacturing, Biovanix Oligo dT(25) Resin supports the full spectrum of mRNA applications.
Vaccine Production
Efficient purification of mRNA vaccines.
Gene Therapy
Scalable production of mRNA for therapeutic applications.
IVT Manufacturing
Streamlined isolation of mRNA from transcription reaction mixtures.
Plasmid DNA Removal
Effective elimination of plasmid DNA and other IVT components.
Customer Testimonial
“Biovanix InertShell Chromatography Resin has transformed our virus purification process. The dual functionality and high selectivity have significantly improved our yields and purity levels, making it an essential tool in our testings.”
– Alex, Developer, AA Biopharma
